Australia's largest stock trading and investment forum Australia's #1 stock forum

KKL

Click for more information

0.00%

1.5¢ kollakorn corporation limited

Funny that isn't it - first, it was performance shares launching...

First 9 Last

Share
Profile

Follow
BohannonsVest

6,677 Posts.

186

27/11/17

12:58

Post #: 29143679
Share

Originally posted by Arkie ↑

I know that this isn't meant to be a forecast however this is a major downgrade in sentiment on Isity.

"The warrantors will put at risk the shares that have been presented. These will be put in escrow until July 2019 and the achievement of a minimum profit of $500k in FY 2019"

And....

"In all transactions such as this, a significant degree of post contract review occurs after the parties have formalised the contracts, and adjustments are made to the business accordingly. Kollakorn has been no different." What, they didn't do this in their DD beforehand!?? They already new each other business, as mates. BS!

I'll continue to hold in my SMSF only.

Expand

Funny that isn't it - first, it was performance shares launching from a annual base of $8 mill; now, it's we hope to make $500k 2 years from now.

KKL Price at posting: 3.9¢ Sentiment: None Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BUX

Buxton projects new graphite province discovery at WA Narryer play

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

There are more pages in this discussion • 42 more messages in this thread...

First 9 Last

Add KKL (ASX) to my watchlist